Pfizer to Acquire Global Blood Therapeutics to Enhance Presence in Rare Hematology

Pfizer Inc and Global Blood Therapeutics, Inc announced in a press release that the companies have entered into a definitive agreement under which Pfizer will acquire GBT, a biopharmaceutical company dedicated to the discovery, development and delivery of life-changing treatments that provide hope to underserved patient communities, starting with sickle...

Read More